The effect of continuous infusion ?of Meropenem antibiotic ?? in Clinical ?symptoms and Procalcitonin changes in sever sepsis
Phase 2
Recruiting
- Conditions
- Acute sepsis.Streptococcal sepsis, unspecified
- Registration Number
- IRCT20141209020258N65
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
18-75 years
Patients admitted to ICU with the diagnosis of evidence of infection and at least two of the symptoms of SIRS (sepsis)
Exclusion Criteria
Incidence of drug-related complications
No response to treatment within 72 hours
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in Procalcitonin. Timepoint: Before and 2 weeks after treatment. Method of measurement: milligram.;GFR. Timepoint: Before and 2 weeks after treatment. Method of measurement: count.;Level of consciousness. Timepoint: At the time of arrival, 24, 48 and 72 hours after receiving the drug. Method of measurement: Glasgow scale.;Incidence of mortality. Timepoint: Before and 2 weeks after treatment. Method of measurement: Number.
- Secondary Outcome Measures
Name Time Method